A statistical comparison of prognostic index systems for brain metastases after stereotactic radiosurgery or fractionated stereotactic radiation therapy

Clinical Oncology

Volumn 25, Issue 4, 2013, Pages 227-235

  Rodrigues, G ^a,b   Gonzalez Maldonado, S ^a   Bauman, G ^a   Senan, S ^c   Lagerwaard, F ^c  

^a LONDON REGIONAL CANCER PROGRAM   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Brain metastases; Decision curve analysis; Operating characteristics; Prognostic index

Indexed keywords

ADULT; ARTICLE; BRAIN METASTASIS; CANCER CLASSIFICATION; CANCER GRADING; CANCER PATIENT; CANCER PROGNOSIS; CONTROLLED STUDY; DATA BASE; DECISION CURVE ANALYSIS; FRACTIONATED STEREOTACTIC RADIATION THERAPY; GOLDEN GRADING SYSTEM; HUMAN; INTEGRATED DISCRIMINATION IMPROVEMENT INDEX; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; NET RECLASSIFICATION IMPROVEMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; ROTTERDAM INDEX; STEREOTACTIC RADIOSURGERY; STEREOTACTIC TREATMENT;

BRAIN NEOPLASMS; DOSE FRACTIONATION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOSURGERY; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84875369682     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2012.11.006     Document Type: Article

References (33)

1. Tsao M.N., Rades D., Wirth A., et al. Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): an American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol 2012, 2(3):210-225.
2. Tsao M.N., Rades A., Wirth A., et al. International practice survey on the management of brain metastases: Third International Consensus Workshop on palliative radiotherapy and symptom control. Clin Oncol 2012, 24(6):e18.
3. Rodrigues G., Warner A., Bauman G., Senan S., Lagerwaard F. Systematic review of fractionated brain metastases radiotherapy. J Radiat Oncol 2012, 10.1007/s13566-012-0035-x.
4. Nieder C., Mehta M.P. Prognostic indices for brain metastases - usefulness and challenges. Radiat Oncol 2009, 4:10.
5. Rodrigues G., Bauman G., Palma D., et al. Systematic review of brain metastases prognostic indices. Pract Radiat Oncol 2012, 10.1016/j.prro.2012.04.001.
6. Gaspar L., Scott C., Rotman M., et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997, 37(4):745-751.
7. Lagerwaard F.J., Levendag P.C., Nowak P.J., et al. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 1999, 43(4):795-803.
8. Weltman E., Salvajoli J.V., Brandt R.A., et al. Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys 2000, 46(5):1155-1161.
9. Lorenzoni J., Devriendt D., Massager N., et al. Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. Int J Radiat Oncol Biol Phys 2004, 60(1):218-224.
10. Sperduto P.W., Berkey B., Gaspar L.E., Mehta M., Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008, 70(2):510-514.
11. Rades D., Dunst J., Schild S.E. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases. Strahlenther Onkol 2008, 184(5):251-255.
12. Golden D.W., Lamborn K.R., McDermott M.W., et al. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site. J Neurosurg 2008, 109(Suppl.):77-86.
13. Sperduto P.W., Chao S.T., Sneed P.K., et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4259 patients. Int J Radiat Oncol Biol Phys 2010, 77(3):655-661.
14. Sperduto P.W., Kased N., Roberge D., et al. Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 2012, 30(4):419-425.
15. Rades D., Dziggel L., Haatanen T., et al. Scoring systems to estimate intracerebral control and survival rates of patients irradiated for brain metastases. Int J Radiat Oncol Biol Phys 2011, 80(4):1122-1127.
16. Gaspar L.E., Scott C., Murray K., Curran W. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 2000, 47(4):1001-1006.
17. Nieder C., Nestle U., Motaref B., Walter K., Niewald M., Schnabel K. Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes?. Int J Radiat Oncol Biol Phys 2000, 46(2):297-302.
18. Fleckenstein K., Hof H., Lohr F., Wenz F., Wannenmacher M. Prognostic factors for brain metastases after whole brain radiotherapy. Data from a single institution. Strahlenther Onkol 2004, 180(5):268-273.
19. Paek S.H., Audu P.B., Sperling M.R., Cho J., Andrews D.W. Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques. Neurosurgery 2005, 56(5):1021-1034.
20. Saito E.Y., Viani G.A., Ferrigno R., et al. Whole brain radiation therapy in management of brain metastasis: results and prognostic factors. Radiat Oncol 2006, 1:20.
21. Lagerwaard F.J., Levendag P.C. Prognostic factors in patients with brain metastases. Forum (Genova) 2001, 11:27-46.
22. Viani G.A., Bernardes da Silva L.G., Stefano E.J. Prognostic indexes for brain metastases: which is the most powerful?. Int J Radiat Oncol Biol Phys 2012, 83:e325-e330.
23. Rodrigues G., Eppinga W., Lagerwaard F., et al. A pooled analysis of arc-based image-guided simultaneous integrated boost radiation therapy for oligometastatic brain metastases. Radiother Oncol 2012, 102:180-186.
24. Lagerwaard F.J., van der Hoorn E.A., Verbakel W.F., Haasbeek C.J., Slotman B.J., Senan S. Whole-brain radiotherapy with simultaneous integrated boost to multiple brain metastases using volumetric modulated arc therapy. Int J Radiat Oncol Biol Phys 2009, 75:253-259.
25. Bauman G., Yartsev S., Fisher B., et al. Simultaneous infield boost with helical tomotherapy for patients with 1 to 3 brain metastases. Am J Clin Oncol 2007, 30:38-44.
26. Rodrigues G., Yartsev S., Yaremko B., et al. Phase I trial of simultaneous in-field boost with helical tomotherapy for patients with one to three brain metastases. Int J Radiat Oncol Biol Phys 2011, 80:1128-1133.
27. Heagerty P.J., Lumley T., Pepe M.S. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000, 56:337-344.
28. Pencina M.J., D'Agostino R.B., D'Agostino R.B., Vasan R.S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008, 27:157-172.
29. Pencina M.J., D'Agostino R.B., Steyerberg E.W. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 2010, 30:11-21.
30. Vickers A.J., Elkin E.B. Decision curve analysis: a novel method for evaluating prediction models. Med Decision Making 2006, 26:565-574.
31. Baker S.G., Cook N.R., Vickers A., Kramer B.S. Using relative utility curves to evaluate risk prediction. J R Stat Soc Ser A Stat Soc 2009, 172:729-748.
32. Vickers A.J., Cronin A.M., Elkin E.B., Gonen M. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inform Decision Making 2008, 8:53.
33. R: a language and environment for statistical computing 2011, R Development Core Team, R Foundation for Statistical Computing, Vienna. http://www.R-project.org/.